EUDA Health Holdings Limited Ordinary Shares

EUDA

EUDA Health Holdings Limited is a healthcare company that focuses on the development and commercialization of innovative medical and healthcare products. It operates through various segments, including medical devices, healthcare services, and related technologies, aiming to enhance patient care and medical outcomes. The company is engaged in research, manufacturing, and distribution within the healthcare sector.

$11.30 -1.79 (-13.64%)
đźš« EUDA Health Holdings Limited Ordinary Shares does not pay dividends

Company News

EUDA Highlights Shenzhen Inno’s Approval Under Shenzhen Key Industry R&D Program for TCR-T Cell Therapy Development
GlobeNewswire Inc. • Euda Health Holdings Limited • April 28, 2026

EUDA Health Holdings announced that its partner Shenzhen Inno Immune received government approval under the 2025 Shenzhen Key Industry R&D Program to develop TCR-T cell therapies for solid tumors, with potential funding of approximately $434,688. EUDA holds distribution rights for selected immunotherapies in Malaysia through this partnership.

EUDA Health Holdings Limited Has Received Notice from Nasdaq that it has Failed to Maintain a Minimum Market Value of its Listed Securities
GlobeNewswire Inc. • Na • April 27, 2026

EUDA Health Holdings Limited received a notice from Nasdaq on April 23, 2026, indicating it failed to maintain the required minimum market value of listed securities of $35 million. The company has 180 calendar days until October 20, 2026, to regain compliance by achieving a market value of $35 million or more for at least ten consecutive busines...

EUDA Accelerates Longevity Strategy with Launch of Comprehensive Stem Cell Therapy Platform and First Clinic in Shenzhen
GlobeNewswire Inc. • Euda Health Holdings Limited • December 23, 2025

EUDA Health Holdings announced a major expansion of its longevity and regenerative medicine strategy by launching a comprehensive stem cell therapy platform and establishing its first clinic in Shenzhen, China. The company is upgrading Shenzhen Inno's cGMP facility to incorporate iPSC technology from GO POSB and Japanese partners, while opening a...

EUDA Health Holdings Limited Completes Acquisition of CK Health Plus Sdn Bhd, Expanding into Direct Selling Holistic Wellness Products in Southeast Asia
GlobeNewswire Inc. • EUDA Health Holdings Ltd • May 8, 2024

Singapore, May 08, 2024 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited (“EUDA” or the “Company”) (NASDAQ: EUDA), a Singapore-based health technology company that operates a first-of-its-kind Southeast Asian digital healthcare ecosystem, proudly announces the successful completion of its acquisition of CK Health Plus Sdn Bhd (“CK Hea...

EUDA Health Expands into Direct Selling Holistic Wellness Products with Acquisition of CK Health
GlobeNewswire Inc. • EUDA Health Holdings Ltd • May 6, 2024

SINGAPORE, May 06, 2024 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited (“EUDA” or the “Company”) (NASDAQ: EUDA), a Singapore-based health technology company that operates a first-of-its-kind Southeast Asian digital healthcare ecosystem, today announced that it will acquire CK Health Plus Sdn Bhd (“CK Health”), a direct seller of h...

Related Companies